Sign in
Taking people in Hong KongNo phase

Conversation tool for older adults with advanced chronic kidney disease choosing treatment

Tests a conversation aid for older adults with advanced kidney disease and clinicians.

Key facts

Who runs it
The University of Hong Kong
Where
Hong Kong, Hong KongSee the site
Trial code
Registry title
A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
Status
Recruiting
People taking part
280 people, planned
Started
4 Feb 2025
Expected to end
30 Sept 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • "CKD Jumpstart- Tips" priming intervention
Record updated
8 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for older adults with advanced kidney disease (stage 4 or 5) and the kidney doctors who care for them. It tests a tool that helps patients and doctors decide on treatment together.

Age
65 years or older
Sex
All sexes can join.
Disease stage
Advanced chronic kidney disease, stage 4 or 5: eGFR of 20 or lower and creatinine of 350 umol/L (3.96 mg/dL) or higher on two measurements at least 90 days apart in the prior year.
Earlier treatment
Patients cannot have a confirmed treatment decision for dialysis, palliative care or kidney transplant, and cannot have started any of these treatments.
Biomarker or test result
eGFR of 20 or lower and creatinine level of 350 umol/L (3.96 mg/dL) or higher on two measurements at least 90 days apart in the prior year.

Main reasons for not taking part

  • A confirmed treatment decision for dialysis, palliative care or kidney transplant noted in the clinical notes
  • Having already started dialysis, palliative care or a kidney transplant
  • Not able to make decisions for themselves

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Clinicians; Nephrology specialists or higher physician trainees who provide specialty care to older adults with advanced chronic kidney disease
  • Patients; Diagnosis of advanced CKD Stage 4 or 5 defined by estimated Glomerular Filtration Rate (eGFR) of ≤ 20 and a creatinine level ≥350 (umol/L) on two measurements at least 90 days apart in the prior year; Chinese- or English-speaking; Able to provide written informed consent and complete questionnaires; Can be contacted by phone

Who cannot take part

  • have a confirmed advanced CKD treatment decision for dialysis, palliative care, or renal transplant documented in clinical notes
  • Patients will be excluded if they
  • have initiated any of these treatments
  • lack decision-making capacity

Where in Hong Kong

  • Queen Mary HospitalHong Kong, Hong KongContact: Jacqueline KY YuenTaking people

About the trial

What the trial wants to find out

To achieve the goal of reaching consensus about the preferred treatment option that best aligns with the goals and values of patients, the investigators developed a 'CKD Jumpstart- Tips" priming tool tailored for older adults with advanced CKD that is based on communication principles from VitalTalk and Elwyn's goal-based SDM model.

Read full original descriptionShow less

The investigators hypothesize that compared with patients in the usual care group, patients in the 'CKD Jumpstart- Tips' intervention group will have:

1. increased level of shared decision-making (observer-based and patient-reported), 2. improved quality of communication, 3. increased patient involvement in decision-making, 4. lower decisional conflict, 5. lower decision regret, 6. decreased time to decision, 7. improved adherence to treatment choice, and 8. improved health-related quality-of-life.

The 2 groups in the trial

  • Priming Intervention armTreatment being tested

    Patients in the priming intervention arm will be provided and are expected to complete the "CKD Jumpstart- Tips" communication priming tool prior to a target clinic visit. Within one week prior to and on the day of the target clinic visit, patients will receive a "CKD Jumpstart- Tips" patient summary sheet which includes a summary of survey responses that can be shared with their healthcare team and tips on communication with clinician during upcoming visit. Clinicians in the priming intervention arm will receive a "CKD Jumpstart- Tips" clinician priming sheet in the patient's medical chart within one week prior to and on the day of the target clinic visit. The priming sheet includes an abstracted version of the patients' survey responses and communication tips tailored to the patient's responses based on Vitaltalk curricular materials.

    Treatment: "CKD Jumpstart- Tips" priming intervention

  • Usual care armNo study treatment, for comparison

    Additional education classes and information in written or multimedia formats reviewing kidney failure treatment options will be made available per routine care and will not be dictated by the study. Patients will be asked whether they have attended an education session or provided informational materials at baseline.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced Chronic Kidney Disease and Clinicians: A Cluster-Randomized Controlled Trial
Plain-language title
Conversation tool for older adults with advanced chronic kidney disease choosing treatmentGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
8 September 2026